Comparison of Composite Measures of Disease Activity in Psoriatic Arthritis Using Data From an Interventional Study With Golimumab

Publisher： John Wiley & Sons Inc

E-ISSN： 2151-4658|66|5|749-756

ISSN： 2151-464x

Source： ARTHRITIS CARE AND RESEARCH, Vol.66, Iss.5, 2014-05, pp. : 749-756

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Analysis of Trial Data for Infliximab and Golimumab: Baseline C‐Reactive Protein Level and Prediction of Therapeutic Response in Patients With Psoriatic Arthritis

By  

ARTHRITIS CARE AND RESEARCH, Vol. 66, Iss. 7, 2014-07 ,pp. : 1114-1118

John Wiley & Sons Inc

Access to resources Recommend Favorite

Minimal Disease Activity and Anti–Tumor Necrosis Factor Therapy in Psoriatic Arthritis

By  

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 6, 2015-05 ,pp. : 842-847

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Randomized Phase IIb Study of Mavrilimumab and Golimumab in Rheumatoid Arthritis

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 70, Iss. 1, 2018-01 ,pp. : 49-59

John Wiley & Sons Inc

Access to resources Recommend Favorite

Factors Explaining the Discrepancy Between Physician and Patient Global Assessment of Joint and Skin Disease Activity in Psoriatic Arthritis Patients

By  

ARTHRITIS CARE AND RESEARCH, Vol. 67, Iss. 2, 2015-02 ,pp. : 264-272

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of screening questionnaires to identify psoriatic arthritis in a primary‐care population: a cross‐sectional study

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 175, Iss. 3, 2016-09 ,pp. : 542-548

John Wiley & Sons Inc

Access to resources Recommend Favorite